Condition (MeSH)
Oligohydramnios
ClinicalTrials.gov lists 24 trials for Oligohydramnios or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
24 of the 24 trials are tagged with Oligohydramnios itself; the rest are tagged with a narrower condition beneath it.
When did Oligohydramnios trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 3 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 2 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 1 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Oligohydramnios trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 3 |
| Phase 4 | 2 |
| Not applicable | 8 |
| Observational | 8 |
How many Oligohydramnios trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Completed | 9 |
| Terminated | 2 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Oligohydramnios trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Kayseri Education and Research Hospital | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| Antalya Training and Research Hospital | 1 |
| Deepecho | 1 |
| Hillel Yaffe Medical Center | 1 |
Which drugs are being tested for Oligohydramnios? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| MisoprostoL | 1 |
| SILDENAFIL | 1 |
| Isosorbide Mononitrate | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Tolvaptan IR | 2 |
| IV/Oral Hydration and Bedrest | 1 |
| Warfarin VKA | 1 |
| anti oxidant omega 3 | 1 |
| low sodium diet | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Oligohydramnios? (51)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis: The Renal Anhydramnios Fetal Therapy Trial. | JAMA | 2023 | Yes |
| NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians | 2022 | Yes |
| Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group. | Nature reviews. Urology | 2022 | Yes |
| Design and Protocol of the Renal Anhydramnios Fetal Therapy (RAFT) Trial. | Clinical therapeutics | 2022 | Yes |
| Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries. | Reproductive health | 2020 | Yes |
Showing 5 of 51 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.